[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100634074":3},{"organization":4,"armGroups":7,"interventions":25,"overallOfficials":31,"centralContacts":40,"locations":46,"responsibleParty":75,"collaborators":31,"id":78,"slug":79,"hasResults":80,"nctId":81,"briefTitle":82,"officialTitle":83,"acronym":31,"eligibilityCriteria":84,"healthyVolunteers":85,"sex":86,"minAge":87,"maxAge":88,"enrollmentInfo":89,"targetDuration":31,"studyType":92,"phases":93,"briefSummary":95,"conditions":96,"keywords":101,"overallStatus":49,"whyStopped":31,"lastUpdateSubmitDate":108,"lastUpdatePostDateStruct":109,"startDateStruct":112,"completionDateStruct":114,"leadSponsor":116,"locationsCount":117},{"fullName":5,"class":6},"Marmara University Pendik Training and Research Hospital","OTHER",[8,14,19],{"label":9,"type":10,"description":11,"interventionNames":12},"Paedfusor Group","EXPERIMENTAL","Anesthesia will be maintained using propofol with target-controlled infusion based on the Paedfusor pharmacokinetic model.",[13],"Drug: propofol ( Paedfusor Model)",{"label":15,"type":10,"description":16,"interventionNames":17},"Eleveld Group","Anesthesia will be maintained using propofol with target-controlled infusion based on the Eleveld pharmacokinetic model.",[18],"Drug: propofol (Eleveld Model)",{"label":20,"type":21,"description":22,"interventionNames":23},"Sevoflurane Group","ACTIVE_COMPARATOR","Anesthesia will be maintained using sevoflurane inhalational anesthesia.",[24],"Drug: Sevofluorane",[26,32,36],{"type":27,"name":28,"description":29,"armGroupLabels":30,"otherNames":31},"DRUG","propofol ( Paedfusor Model)","Propofol will be administered via target-controlled infusion using a Paedfusor model.",[9],null,{"type":27,"name":33,"description":34,"armGroupLabels":35,"otherNames":31},"propofol (Eleveld Model)","Propofol will be administered via target-controlled infusion using the Eleveld model.",[15],{"type":27,"name":37,"description":38,"armGroupLabels":39,"otherNames":31},"Sevofluorane","Sevoflurane will be administered as an inhalation anesthetic.",[20],[41],{"name":42,"role":43,"phone":44,"phoneExt":31,"email":45},"Rukiye Seyma Eslek","CONTACT","+90 539 573 5400","seyma.eslek@gmail.com",[47,63],{"facility":48,"status":49,"city":50,"state":31,"zip":51,"country":52,"countryCode":31,"cosmosGeoPoint":53,"geoPoint":58,"contacts":59},"Marmara University Pendik Research and Training Hospital","RECRUITING","Istanbul","34890","Turkey (Türkiye)",{"type":54,"coordinates":55},"Point",[56,57],28.94966,41.01384,{"lat":57,"lon":56},[60],{"name":61,"role":43,"phone":62,"phoneExt":31,"email":45},"Rukiye Seyma Eslek, MD","+90 539 5735400",{"facility":48,"status":49,"city":50,"state":31,"zip":51,"country":52,"countryCode":31,"cosmosGeoPoint":64,"geoPoint":66,"contacts":67},{"type":54,"coordinates":65},[56,57],{"lat":57,"lon":56},[68,70,73],{"name":69,"role":43,"phone":44,"phoneExt":31,"email":45},"Rukiye Seyma Eslek, MD (Resident)",{"name":71,"role":72,"phone":31,"phoneExt":31,"email":31},"Nazan Atalan Özlen","PRINCIPAL_INVESTIGATOR",{"name":61,"role":74,"phone":31,"phoneExt":31,"email":31},"SUB_INVESTIGATOR",{"type":72,"investigatorFullName":76,"investigatorTitle":77,"investigatorAffiliation":5,"oldNameTitle":31,"oldOrganization":31},"dilara gocmen","Assist prof","100634074","the-effect-of-paedfusor-tci-eleveld-tci-and-sevoflurane-anesthesia-on-postoperative-awakening-agitation-in-pediatric-patients-100634074",false,"NCT07534956","The Effect of Paedfusor TCI, Eleveld TCI, and Sevoflurane Anesthesia on Postoperative Awakening Agitation in Pediatric Patients","Investigation of the Effects of Two Different TCI (Target Controlled Infusion) Models (Paedfusor and Eleveld) and Inhalation Anesthesia on Postoperative Awakening Agitation\u002FDelirium in Pediatric Patients","Inclusion Criteria:\n\n* Children aged 3-10 years\n* Children weighing over 10 kg\n* American Society of Anesthesiologists (ASA) physical condition classification I-II\n* Those who will undergo planned urogenital surgery under general anesthesia\n* Those who have obtained written informed consent from their parents or legal guardians\n\nExclusion Criteria:\n\n* Patients assessed as ASA III or higher\n* Known neurological or psychiatric disorders\n* Developmental delay or cognitive impairment\n* Use of sedatives or psychoactive drugs\n* Allergy or contraindication to the study drugs (propofol or sevoflurane)\n* History of previous adverse reactions to anesthesia\n* Patients requiring emergency surgery\n* Significant liver, kidney, or cardiovascular disease\n* Patients whose parents or legal guardians have not given consent",true,"ALL","3 Years","10 Years",{"count":90,"type":91},150,"ESTIMATED","INTERVENTIONAL",[94],"NA","Emergence delirium is a common complication in pediatric patients undergoing general anesthesia. The aim of this study is to investigate the incidence of postoperative awakening delirium and agitation in pediatric patients aged 3-10 years (ASA I-II) using two different target-controlled infusion (TCI) methods (Paedfusor and Eleveld) for TIVA, compared to inhalation anesthesia. This study will examine the effect of two different TCI models on postoperative awakening agitation\u002Fdelirium by comparing them with each other and with inhalation anesthesia.",[97,98,99,100],"Emergence Delirium in Pediatric Anesthesia","Pediatric Anesthesia","Postoperative Agitations in Pediatric Patients","Postoperative Nausea and Vomiting (PONV)",[102,103,104,105,106,107],"pediatric anesthesia","paedfusor","eleveld","target controlled infusion","sevoflurane","postoperative agitation","2026-04-11",{"date":110,"type":111},"2026-04-16","ACTUAL",{"date":113,"type":111},"2026-01-13",{"date":115,"type":91},"2027-11-30",{"name":5,"class":6},2]